Antibody drug conjugates market accounted for $1,387 million in 2016, and is estimated to reach at $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023. Antibody drug conjugates are highly powerful biopharmaceutical medications prepared by integrating two principles i.e. a cell killing highly powerful active pharmaceutical ingredient (HPAPI) and explicit nature …
Continue reading “Antibody Drug Conjugates Market Expected to Reach $3,198 Million by 2023”